Evidence map›Paper›PMID 22266761›Full record

ReviewNature reviews. Molecular cell biology2012

Understanding the language of Lys36 methylation at histone H3.

Eric J Wagner, Phillip B Carpenter

Abstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 590 papers.

0numbers the graph read from it
0cells of the map it votes in
590citing papers in PubMed
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

590 citing papers in PubMed, 948 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A PHD-zinc finger-mediated mechanism for PHF21B recognition of H3K36me3.Genomic psychiatry : advancing science from genes to society · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

530 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Eric J WagnerDepartment of Biochemistry and Molecular Biology, The University of Texas Medical School, Houston, Texas 77030, USA. Eric.J.Wagner@uth.tmc.edu
Phillip B Carpenter
Texas Medical Center · USThe University of Texas Health Science Center at Houston · US

Funding

Characterizing Novel Components Involved in 3' End Processing of Histone pre-mRNAR00GM080447 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WAGNER, ERIC J · 2008 to 2010
$745k
NIGMS NIH HHS 5R00GM080447NIGMS NIH HHS R00 GM080447
6 · The paper itself

Abstract

Histone side chains are post-translationally modified at multiple sites, including at Lys36 on histone H3 (H3K36). Several enzymes from yeast and humans, including the methyltransferases SET domain-containing 2 (Set2) and nuclear receptor SET domain-containing 1 (NSD1), respectively, alter the methylation status of H3K36, and significant progress has been made in understanding how they affect chromatin structure and function. Although H3K36 methylation is most commonly associated with the transcription of active euchromatin, it has also been implicated in diverse processes, including alternative splicing, dosage compensation and transcriptional repression, as well as DNA repair and recombination. Disrupted placement of methylated H3K36 within the chromatin landscape can lead to a range of human diseases, underscoring the importance of this modification.

Indexed as

AnimalsComprehensionGene ExpressionHistone-Lysine N-MethyltransferaseHistonesHumansLysineMethylationModels, BiologicalProtein Processing, Post-TranslationalHistone-Lysine N-MethyltransferaseHistonesLysine

Identifiers

PMID22266761
PMCPMC3969746
OpenAlexW1969451832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.